Cargando…
Latent class analysis identifies functional decline with Amsterdam IADL in preclinical Alzheimer's disease
INTRODUCTION: Trials in Alzheimer's disease (AD) now include participants at the earliest stages to prevent further decline. However, the lack of tools sensitive to subtle functional changes in early-stage AD hinders the development of new therapies as it is difficult to prove their clinical re...
Autores principales: | Villeneuve, Sarah-Christine, Houot, Marion, Cacciamani, Federica, Verrijp, Merike, Dubois, Bruno, Sikkes, Sietske, Epelbaum, Stéphane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804616/ https://www.ncbi.nlm.nih.gov/pubmed/31650012 http://dx.doi.org/10.1016/j.trci.2019.08.009 |
Ejemplares similares
-
The influence of diversity on the measurement of functional impairment: An international validation of the Amsterdam IADL Questionnaire in eight countries
por: Dubbelman, Mark A., et al.
Publicado: (2020) -
Enhancing ‘meaningfulness’ of functional assessments: UK adaptation of the Amsterdam IADL questionnaire
por: Stringer, Gemma, et al.
Publicado: (2021) -
Awareness of Cognitive Decline in Patients With Alzheimer's Disease: A Systematic Review and Meta-Analysis
por: Cacciamani, Federica, et al.
Publicado: (2021) -
Detecting functional decline from normal aging to dementia: Development and validation of a short version of the Amsterdam IADL Questionnaire
por: Jutten, Roos J., et al.
Publicado: (2017) -
Awareness of cognitive decline trajectories in asymptomatic individuals at risk for AD
por: Cacciamani, Federica, et al.
Publicado: (2020)